IMMUNOCORE HLDGS ADS/1 (6YG) — Cash Flow Quality Index

Latest as of March 2026: -1.06x

IMMUNOCORE HLDGS ADS/1 (6YG) has a Cash Flow Quality Index of -1.06x as of March 2026. Operating cash flow of €-13.78 Million is below net income of €12.97 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore IMMUNOCORE HLDGS ADS/1 cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.06x

Operating CF / Net Income

Operating Cash Flow

€-13.78 Million

EUR

Net Income

€12.97 Million

EUR

Data as of

Mar 2026

Most recent filing

Annual Cash Flow Quality Index for IMMUNOCORE HLDGS ADS/1 (None–None)

Year-by-year earnings quality comparison for IMMUNOCORE HLDGS ADS/1.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.